BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38521111)

  • 61. Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes.
    Zou J; Luo H; Zeng Q; Dong Z; Wu D; Liu L
    J Transl Med; 2011 Jun; 9():97. PubMed ID: 21702981
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term resistance to 5-fluorouracil promotes epithelial-mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells.
    Sousa-Squiavinato ACM; Arregui Ramos DA; Wagner MS; Tessmann JW; de-Freitas-Junior JCM; Morgado-Díaz JA
    Eur J Pharmacol; 2022 Oct; 933():175253. PubMed ID: 36067803
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alpha B-crystallin promotes the invasion and metastasis of colorectal cancer via epithelial-mesenchymal transition.
    Shi C; Yang X; Bu X; Hou N; Chen P
    Biochem Biophys Res Commun; 2017 Aug; 489(4):369-374. PubMed ID: 28506831
    [TBL] [Abstract][Full Text] [Related]  

  • 64. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
    Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
    Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition.
    Zhou HM; Dong TT; Wang LL; Feng B; Zhao HC; Fan XK; Zheng MH
    World J Gastroenterol; 2012 Jun; 18(21):2640-8. PubMed ID: 22690072
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Voltage-gated sodium channel Na
    Sui Q; Peng J; Han K; Lin J; Zhang R; Ou Q; Qin J; Deng Y; Zhou W; Kong L; Tang J; Xiao B; Li Y; Yu L; Fang Y; Ding PR; Pan Z
    Cancer Lett; 2021 Mar; 500():119-131. PubMed ID: 33338532
    [TBL] [Abstract][Full Text] [Related]  

  • 67. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
    Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
    World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
    [TBL] [Abstract][Full Text] [Related]  

  • 68. APOA5 alleviates reactive oxygen species to promote oxaliplatin resistance in PIK3CA-mutated colorectal cancer.
    Liu YL; Xiang Z; Zhang BY; Zou YW; Chen GL; Yin L; Shi YL; Xu LL; Bi J; Wang Q
    Aging (Albany NY); 2024 Jun; 16(11):9410-9436. PubMed ID: 38848145
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
    Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
    Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
    [TBL] [Abstract][Full Text] [Related]  

  • 70. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
    Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
    Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regulation of ATP-binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer.
    Wang H; Li JM; Wei W; Yang R; Chen D; Ma XD; Jiang GM; Wang BL
    Cancer Sci; 2020 Jan; 111(1):84-97. PubMed ID: 31774615
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circ_0026344 restrains metastasis of human colorectal cancer cells via miR-183.
    Shen T; Cheng X; Liu X; Xia C; Zhang H; Pan D; Zhang X; Li Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4038-4045. PubMed ID: 31608699
    [No Abstract]   [Full Text] [Related]  

  • 74. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
    Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
    Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
    Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
    Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.
    Karimi Dermani F; Saidijam M; Amini R; Mahdavinezhad A; Heydari K; Najafi R
    J Cell Biochem; 2017 Jun; 118(6):1547-1555. PubMed ID: 27918105
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.
    Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
    Oncotarget; 2016 Sep; 7(39):64136-64147. PubMed ID: 27580057
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer.
    Zhang B; Chan SH; Liu XQ; Shi YY; Dong ZX; Shao XR; Zheng LY; Mai ZY; Fang TL; Deng LZ; Zhou DS; Chen SN; Li M; Zhang XD
    J Cell Mol Med; 2021 Sep; 25(18):8836-8849. PubMed ID: 34378321
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells.
    Lu WQ; Hu YY; Lin XP; Fan W
    Oncotarget; 2017 Jul; 8(27):44171-44185. PubMed ID: 28498807
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
    Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
    Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.